Pleuropericarditis in a patient with inflammatory bowel disease: a case presentation and review of the literature.
Inflammatory bowel disease (IBD) can affect the lung parenchyma and airways. Rarely it involves the pleural space and pericardium, causing inflammatory exudative pleural and/or pericardial effusions. In this report, we describe a 76-year-old patient with recurrent sterile exudative pleuropericarditis that gradually responded to treatment with steroids, and we review the relevant literature. Thoracic serositis in patients with IBD can cause pleuritis, pericarditis, pleuropericarditis, or myopericarditis. This is a relatively rare presentation of the uncommon and probably underreported and underrecognized pulmonary extraintestinal manifestations of IBD. Pleuropericardial inflammatory disease and effusion can be directly related to IBD, its complications, associated infections, or the medications used to treat it. Serositis directly related to IBD is a diagnosis of exclusion. It is important to evaluate the pleural effusion and rule out other etiologies before making this diagnosis. Pleural or pericardial biopsies are rarely necessary, and probably show nonspecific acute and chronic inflammatory changes. Although the specific pathophysiology of pleuropericardial disease in patients with IBD remains unclear, the response to systemic steroids is usually adequate.
Abu-Hijleh
Muhanned
M
Department of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, Rhode Island Hospital, The Alpert Medical School of Brown University, 593 Eddy Street, APC 7, Providence, RI 02903, USA. Muhanned_Abu-Hijleh@brown.edu
Evans
Samuel
S
Aswad
Bassam
B
D000368:Aged; D001706:Biopsy; D004322:Drainage; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000150:complications*; D008297:Male; D010490:Pericardial Effusion / Q000209:etiology; D010493:Pericarditis / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D010996:Pleural Effusion / Q000209:etiology; D012008:Recurrence; D013256:Steroids / Q000627:therapeutic use; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
D013256:Steroids
Intensive Care Med. 1996 Oct;22(10):1134-5
8923087
Q J Med. 1979 Jan;48(189):93-7
482594
Mt Sinai J Med. 2001 Nov;68(6):384-8
11687866
Arch Intern Med. 1976 Apr;136(4):454-9
1267553
Arch Intern Med. 1983 Jan;143(1):94-6
6849612
Clin Gastroenterol Hepatol. 2007 Dec;5(12):1424-9
17904915
Inflamm Bowel Dis. 2003 Mar;9(2):104-15
12769444
Medicine (Baltimore). 1993 May;72(3):151-83
8502168
Gut. 1996 Nov;39(5):690-7
9014768
Ann Intern Med. 1986 Jan;104(1):17-21
3940500
Thorax. 1988 Sep;43(9):735-6
3194883
Lung. 2008 May-Jun;186(3):167-172
18330638
Gastroenterology. 2005 Sep;129(3):827-36
16143122
Am J Surg Pathol. 2003 Feb;27(2):213-9
12548168
Eur Respir J. 2002 Apr;19(4):756-64
11999006
Br J Hosp Med (Lond). 2008 May;69(5):296-7
18557560
Gastroenterology. 2004 May;126(6):1504-17
15168363
J Clin Gastroenterol. 2001 Mar;32(3):251-4
11246357
J Clin Gastroenterol. 1983 Dec;5(6):517-21
6663044
Gut. 1992 May;33(5):678-82
1612487
Ann Intern Med. 1974 Sep;81(3):406
4852723
Chest. 1985 Mar;87(3):363-7
3971763
Chest. 2007 Feb;131(2):524-32
17296657
Respiration. 2000;67(4):459-63
10940806
West J Med. 1990 Sep;153(3):314-5
2219897
Arch Dis Child. 1990 Nov;65(11):1270-1
2248544
JAMA. 1970 Mar 2;211(9):1540-2
5467054